Yufeng Ba

机构：Zhengzhou University, Hunan Cancer Hospital, Henan Cancer Hospital

发表论文 23 篇 · 总被引 504 次 · h-index 12

代表论文

• Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy (2015 · Oncotarget · 被引 139)
• Silencing lncRNA AGAP2-AS1 Upregulates miR-195-5p to Repress Migration and Invasion of EC Cells via the Decrease of FOSL1 Expression (2020 · Molecular Therapy — Nucleic Acids · 被引 81)
• Berberine induces apoptosis and DNA damage in MG-63 human osteosarcoma cells (2014 · Molecular Medicine Reports · 被引 51)
• Perioperative toripalimab plus neoadjuvant chemotherapy might improve outcomes in resectable esophageal cancer: an interim analysis of a phase III randomized clinical trial (2024 · 癌症：英文版 · 被引 49)
• A phase III study on neoadjuvant chemotherapy versus neoadjuvant toripalimab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: Henan Cancer Hospital Thoracic Oncology Group 1909 (HCHTOG1909) (2021 · Annals of Translational Medicine · 被引 39)
• FoxO3a inhibiting expression of EPS8 to prevent progression of NSCLC: A new negative loop of EGFR signaling (2019 · EBioMedicine · 被引 25)